ДИАБЕТИК МАКУЛА ШИШИНИ ДАВОЛАШДА БЎСАҒА ОСТИ МИКРОИМПУЛЬС ЛАЗЕРЛИ ТАЪСИРЛАШНИНГ РИВОЖЛАНИШ ЖИҲАТЛАРИ (АДАБИЁТЛАР ТАХЛИЛИ)
DOI:
https://doi.org/10.57231/j.ao.2024.7.1.004Ключевые слова:
диабетик макула шиши, анти-VEGF терапия, бўсаға ости микроимпульс лазерли таъсирлаш, оптик когерент томографияАннотация
Долзарблиги. 2-типдаги қандли диабет билан касалланган мижозларнинг 10-15%да макула шиши (Диабетик макуляр шиш - ДМШ) пайдо бўлиши кузатилади. Тадқиқот мақсади. Кейинги 10-15 йил мобайнида ДМШ даволашда бўсаға ости микроимпульс лазерли даволаш бўйича маълумотларни ўз ичига олган илмий адабиётлар тахлилини ўтказиш. Материал ва усуллар. Республикамизда ва чет элдаги нуфузли нашрларда чоп этилган илмий мақолалар хамда илмий ахборот ресурс манбаларидан фойдаланилган холда уларни ўрганиш. Натижалар ва хулоса. Диабетик макула шишда бўсаға ости микроимпульс лазерли таъсирлашнинг шарҳи тақдим этилган. Тўлқин узунлиги 577 нм бўлган бўсаға ости микроимпульс лазер терапиянинг илмий асосланган ва такрорий услуби ҳисобланади. Лазер таъсирлаш тўр пардасининг қалинлиги унинг шиши билан бирга 400 мкм дан камни ташкил қиладиган мижозларда юқори самарадорликка эга.
Библиографические ссылки
Vorontsova T.N. Possibilities of using a diode laser in diseases of the retina in children. Ophthalmological records. 2008. No. 1. S. 24-28. [In Russ.].
Doga A.V., Kachalina G.F., Pedanova E.K., Buryakov D.A. Comparative study of the effectiveness and safety of the technology of combined laser exposure and traditional laser coagulation in the treatment of diabetic macular edema. Diabetes. 2017;20(1):68-74. [In Russ.]. https://doi.org/10.14341/DM7811
Kirilyuk, M. L. Ishchenko M. L. Pathogenesis of diabetic retinopathy: a review of the literature // International Journal of Endocrinology. - 2019. - V. 15, No. 7. - S. 567-575. [In Russ.]. https://doi.org/24-0721.15.7.2019.186061.
Schmidt-Erfurth U., Garcia-Arumi J., Bandello F. et al. Guidelines for the management of diabetic macular edema by the European Society of Retina Specialists (EURETINA). Ophthalmologica. 2017;237(4): 185-222.//doi.org/10.1159/000458539.
Shaya F.T., Aljawadi M. Diabetic retinopathy. Clin Ophthalmol. 2007;1(3); 259-265.
Bobykin E.V. Modern approaches to the treatment of diabetic macular edema. Ophthalmosurgery. 2019. No. 1. P. 67-76. [In Russ.]. https://doi.org/10.25276/0235-4160-2019-1-67-76
Moisseiev E, Abbassi S, Thinda S, Yoon J, Yiu G, Morse LS. Subthreshold micropulse laser reduces anti-VEGF injection burden in patients with diabetic macular edema. Eur J Ophthalmol. 2018;28:68–73. doi: 10.5301/ejo.5001000.
Fokin V. P., Boriskina L. N., Potapova V. N., Polyakova V. R. Analysis of the effectiveness of a combined treatment method for diabetic macular edema. Vestnik NSU. Series: Biology, clinical medicine. 2011. Vol. 9. Issue. 4. S. 43-47. [In Russ.].
Figueira J., Khan J., Nunes S., et al. Prospective randimized controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema. Br. J. Ophthalmol, 2009, vol. 93, pp. 1341–1314. DOI: 10.1136/bjo.2008.146712
Distefano L.N., Garcia-Arumi J., Martinez-Castillo V. et al. Combination of Anti-VEGF and Laser Photocoagulation for Diabetic Macular Edema: A Review. J. Ophthalmol. 2017:2407037. doi.org/10.1155/2017/2407037.
Singh R., Ramasamy K., Abraham C. et al. Diabetic retinopathy: An update. Indian J. Ophthalmol. 2008;56(3):179-188.
Wong T.Y., Mwamburi M., Klein R. et al. Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis. Diabetes Care. 2009;32(12): 2307-2313. DOI: 10.2337/dc09-0615
MeyerSchwickerath G., Schott К. Diabetic retinopathy and photocoagulation. J. Ophthalmol. – 1968. – Vol. 66. – P. 597-603. DOI: 10.1016/0002-9394(68)91279-8
Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study (ETDRS) report No 1 // Arch. Ophthalmol. - 1985. - Vol. 103. - P. 1796-1806.
Ходжаев Н.С., Черных В.В., Роменская И.В. и соавт. Влияние лазерокоагуляции сетчатки на клинико-лабораторные показатели у пациентов диабетическим макулярным отеком // Вестник НГУ. - 2011. - Т. 9, №4. - C. 48- 53.
Ibragimova, R. R. Promising directions of pathogenetic treatment of diabetic retinopathy and diabetic macular edema / R. R. Ibragimova, T. R. Mukhamadeev // Medical Bulletin of Bashkortostan. - 2020. - T. 15, No. 4 (88). - pp. 108-112. [In Russ.].
Astakhov Yu.S., Nechiporenko P.A. Treatment with aflibercept in patients with diabetic macular edema. Ophthalmological Bulletin Vol. 10, No. 2 (2017) Pages: 94-109. [In Russ.]. https://doi.org/10.17816/OV10294-109
Ionkina I.V., Grinev A.G., Zherebtsova O.M. Approaches to the pharmacotherapy of diabetic macular edema (literature review) // Postgraduate Bulletin of the Volga Region. 2021. No. 1–2. pp. 117–127. [In Russ.]. https://doi.org/10.55531/2072-2354.2021.21.1.117-127
Fursova A.Zh., Chubar N.V., Tarasov M.S., Nikulich I.F., Vasilyeva M.A., Gusarevich O.G. Antiangiogenic therapy for diabetic macular edema. From theory to clinical practice. Bulletin of ophthalmology. 2018;134(2):12 22. [In Russ.]. https://doi.org/10.17116/oftalma2018134212-22
Akopyan V.S., Kachalina G.F., Pedanova E.K., et al. Experimental study of the nature of the tissue response of the chorioretinal complex to subthreshold micropulse laser exposure. // Ophthalmosurgery. - 2015. No. 3. - S. 54-58. [In Russ.].
Vorontsova T.N. Possibilities of using a diode laser in diseases of the retina in children. Ophthalmological records. Volume 1. No. 1. S. 24-28. [In Russ.].
Krylova I.A., Yablokova N.V., Goydin A.P., Fabrikantov O.L. The effectiveness of the treatment of clinically significant diabetic macular edema by the method of subthreshold micropulse laser exposure on the navigation laser system navilas 577s // Modern problems of science and education. - 2021. - No. 5. [In Russ.]. https://doi.org/10.17513/spno.31044
Stanishevskaya O.M., Malinovskaya M.A., Chernykh V.V. The use of subthreshold micropulse laser exposure using a yellow diode laser 577 nm («Quantel medical») in the treatment of macular edema. Modern technologies in ophthalmology. 2016. No. 1. 220-222. [In Russ.].
Pankratov MM. Pulsed delivery of laser energy in experimental thermal retinal photocoagulation. Proc Soc Photo Opt Instrum Eng. 1990;1202:205–13.
Friberg TR, Karatza E. The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser. Ophthalmology 1997;104:2030–2038. DOI: 10.1016/s0161-6420(97)30061-х
Luttrull JK, Musch DC, Mainster MA. Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema. Br J Ophthalmol. 2005;89:74–80. DOI: 10.1136/bjo.2004.051540
Ohkoshi K, Yamaguch T. Subthreshold micropulse diode laser photocoagulation for diabetic macular edema in Japanese patients. Am J Ophthalmol. 2010;149:133–9.
Vujosevic S, Bottega E, Casciano M, Pilotto E, Convento E, Midena E. Microperimetry and fundus autofluorescence in diabetic macular edema: Subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation. Retina. 2010;30:908–16. doi: 10.1097/IAE.0b013e3181c96986.
Yoon Hyung Kwon,1,2 Dong Kyu Lee,2 and Oh Woong Kwon The Short-term Efficacy of Subthreshold Micropulse Yellow (577-nm) Laser Photocoagulation for Diabetic Macular Edema Korean J Ophthalmol. 2014 Oct; 28(5): 379–385. DOI: 10.3341/kjo.2014.28.5.379
Lois N, Gardner E, Waugh N, Azuara-Blanco A, Mistry H, McAuley D, et al. Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial. Trials 2019;20:122. https://doi.org/10.1186/s13063-019-3199-5
Volodin P.L., Ivanova E.V., Polyakova E.Yu., Fomin A.V., Batalov A.I. The use of micropulse and continuous laser radiation in navigational topographically oriented treatment of focal diabetic macular edema. Ophthalmology. 2022;19(3):506-5. [In Russ.]. https://doi.org/10.18008/1816-5095-2022-3-506-514
Mainster MA. Laser-tissue interactions: future laser therapies. Diabetic Retinopathy: Approaches to a Global Epidemic. Association for Research in Vision and Ophthalmology Summer Research Conference 2010; 31 July; Natcher Center, National Institutes of Health, Bethesda MD. 2010
Янгиева, Н., Туйчибаева, Д., & Абасханова, Н. (2014). Применение «цитиколина» в комплексном лечении больных возрастной макулпрной дегенерацией. in Library, 1(1), 33–38. извлечено от https://inlibrary.uz/index.php/archive/article/view/14476
Янгиева, Н. Р., Туйчибаева, Д. М., Абасханова, Н. Х. Возможности ноотропной терапии в комплексном лечении больных первичной открытоугольной глаукомой. Национальный журнал глаукома. 2014;2:70-77. https://www.glaucomajournal.ru/jour/article/view/18/19
Tuychibaeva D. Epidemiological and clinical-functional aspects of the combined course of age-related macular degeneration and primary glaucoma. J.ophthalmol. (Ukraine). 2023;3:3-8. https://doi.org/10.31288/oftalmolzh2023338
Туйчибаева Д.М.. Ким А.А. Современные аспекты лечения кератоконуса. Обзор. Офтальмология. Восточная Европа. 2023;1(13):73-89. [Tuychibaeva D.M., Kim A.А. Modern Aspects of Keratoconus Treatment. A Review. Ophthalmology. Eastern Europe, 2023;13.1:73-89. (in Russ)]. https://doi.org/10.34883/PI.2023.13.1.019
Туйчибаева Д.М. Основные характеристики динамики показателей инвалидности вследствие глаукомы в Узбекистане. Офтальмология. Восточная Европа. 2022;12.2:195-204. [Tuychibaeva D.M. Main Characteristics of the Dynamics of Disability Due to Glaucoma in Uzbekistan. "Ophthalmology. Eastern Europe", 2022;12.2:195-204. (in Russian)]. https://doi.org/10.34883/PI.2022.12.2.027
Tuychibaeva DM. Longitudinal changes in the disability due to glaucoma in Uzbekistan. J.ophthalmol. (Ukraine). 2022;4:12-17. http://doi.org/10.31288/oftalmolzh202241217
Янгиева, Н.Р., Туйчибаева Д.М. Клиническая оценка эффективности комплексного лечения возрастной макулодистрофии // Современные технологии в офтальмологии. – 2017. – № 3. – С. 276-280. – EDN ZENRBT.
Янгиева Н.Р, Туйчибаева Д.М. Эффективность вторичной профилактики возрастной макулярной дегенерации. Биология ва тиббиёт муаммолари. 2021; 21(3):158–161. [Yangieva NR, Tuychibaeva DM. The effectiveness of secondary prevention of age-related macular degeneration. Biology va tibbiyot muammolari. 2021; 21(3):158–161. (In Russ.)].
Agzamova S.S. Improvement of diagnostics and treatment of ophthalmic complications in zygomatic and orbital injuries. "Ophthalmology. Eastern Europe". 2021:11(3);311-320. https://doi.org/10.34883/PI.2021.11.3.030
Агзамова С.С. Ретроспективный анализ состояния офтальмологического статуса при травмах скулоорбитального комплекса. Stomatologiya. 2021;1(82):89–92. https://doi.org/10.34920/2091-5845-2021-29
Туйчибаева ДМ, Янгиева НР. Усовершенствование консервативного лечения возрастной макулодистрофии. Практическая медицина. 2018;16(4): 81–83. [Tuychibaeva DM, Yangieva NR. Improvement of conservative treatment of age-related macular degeneration. Practical medicine. 2018;16(4): 81–83. (In Russia)].
Bakhritdinova F. A., Urmanova F. M., Tuychibaeva D.M. Diagnostic role of angiography optical coherent tomography in diabetic retinopathu. Advanced Opthalmology. 2023;2(2):29-34. DOI: https://doi.org/10.57231/j.ao.2023.2.2.005
Bakhritdinova F. A., Urmanova F. M., Tuychibaeva D.M. Evaluation of the effectiveness of a conservative method of treatment of early srage diabetic retinopathy. - Advanced Opthalmology. - 2023;2(2):35-41. DOI: https://doi.org/10.57231/j.ao.2023.2.2.006
Загрузки
Опубликован
Выпуск
Раздел
Лицензия
Copyright (c) 2024 Гиясова А. О., Янгиева Н. Р.
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.